s 20928 has been researched along with melatonin in 16 studies
| Studies (s 20928) | Trials (s 20928) | Recent Studies (post-2010) (s 20928) | Studies (melatonin) | Trials (melatonin) | Recent Studies (post-2010) (melatonin) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 23,268 | 1,451 | 9,627 |
| Protein | Taxonomy | s 20928 (IC50) | melatonin (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 3 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 3.3323 | |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.0004 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Melatonin receptor type 1A | Homo sapiens (human) | 0.0025 | |
| Melatonin receptor type 1B | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrieux, J; Delagrange, P; Jellimann, C; Langlois, M; Mathé-Allainmat, M; Renard, P | 1 |
| Amossé, C; Audinot, V; Bonnaud, A; Boutin, JA; Delagrange, P; Dromaint, S; Galizzi, JP; Guillaumet, G; Lahaye-Brasseur, C; Le Gall, A; Lefoulon, F; Lesieur, D; Mailliet, F; Malpaux, B; Nagel, N; Renard, P; Rodriguez, M | 1 |
| Bizot-Espiard, JG; Chun, SJ; Guardiola-Lemaitre, B; Hosokawa, M; Nagai, K; Niijima, A; Shima, T | 1 |
| Davies, DJ; Delagrange, P; Dunn, WR; Guardiola-Lemaître, B; Scalbert, E; Sugden, D; Ting, KN; Wilson, VG | 1 |
| Delagrange, P; Guardiola-Lemaître, B; Saavedra, JM; Scalbert, E; Viswanathan, M | 1 |
| Delagrange, P; Guardiola-Lemaitre, B; Guerrero, HY; Masson-Pévet, M; Mocaer, E; Pévet, P; Recio, J | 1 |
| Bizot-Espiard, JG; Cousin, B; Delagrange, P; Doublé, A; Guardiola-Lemaître, B; Ktorza, A; Lesieur, D; Pénicaud, L | 1 |
| Blask, DE; Dauchy, RT; Holowachuk, EW; Kopff, HS; Ruhoff, MS; Sauer, LA | 1 |
| Chu, YS; Pan, JT; Shieh, KR; Yuan, ZF | 1 |
| Delagrange, P; O'Rourke, ST; Scalbert, E; Vanhoutte, PM; Yang, Q | 1 |
| Delagrange, P; Faucheron, JL; Merle, A; Pellissier, S; Renard, P; Roche, M | 1 |
| Blask, DE; Dauchy, RT; Sauer, LA | 1 |
| Blask, DE; Krause, JA; Zalatan, F | 1 |
| Collins, AR; Dai, J; Dubocovich, ML; Hill, SM; Yuan, L | 1 |
| Delagrange, P; Hammad, H; O'Rourke, ST; Scalbert, E; Vanhoutte, PM | 1 |
| Robertson, AD; Willis, GL | 1 |
16 other study(ies) available for s 20928 and melatonin
| Article | Year |
|---|---|
Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Topics: Acetamides; Animals; Brain; Chickens; Chromatography, High Pressure Liquid; In Vitro Techniques; Ligands; Melatonin; Phenalenes; Polycyclic Compounds; Radioligand Assay; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Skin; Stereoisomerism; Structure-Activity Relationship; Xenopus laevis | 1999 |
New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Topics: Animals; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Dose-Response Relationship, Drug; Humans; Ligands; Melatonin; Protein Binding; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2 | 2003 |
Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-D-glucose in rats.
Topics: Animals; Blood Glucose; Cerebral Ventricles; Deoxyglucose; Glucagon; Hyperglycemia; Injections, Intraperitoneal; Injections, Intraventricular; Insulin; Insulin Secretion; Male; Melatonin; Naphthalenes; Rats; Rats, Wistar | 1997 |
Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Free Radical Scavengers; Male; Melatonin; Naphthalenes; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Melatonin receptors mediate contraction of a rat cerebral artery.
Topics: Animals; Cerebral Arteries; In Vitro Techniques; Male; Melatonin; Naphthalenes; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Vasoconstriction | 1997 |
Effects of two melatonin analogues, S-20098 and S-20928, on melatonin receptors in the pars tuberalis of the rat.
Topics: Acetamides; Animals; Autoradiography; Down-Regulation; Male; Melatonin; Naphthalenes; Pineal Gland; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin | 1998 |
Lack of melatonin effects on insulin action in normal rats.
Topics: Animals; Blood Glucose; Cyclopropanes; Glucose Clamp Technique; Imides; Insulin; Kinetics; Male; Melatonin; Naphthalenes; Pineal Gland; Rats; Rats, Wistar | 1998 |
Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Biological Transport; Cell Division; Circadian Rhythm; Colforsin; Linoleic Acid; Linoleic Acids; Liver Neoplasms, Experimental; Male; Melatonin; Models, Biological; Naphthalenes; Perfusion; Pertussis Toxin; Rats; Rats, Inbred BUF; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Signal Transduction; Virulence Factors, Bordetella | 1999 |
Stimulatory and entraining effect of melatonin on tuberoinfundibular dopaminergic neuron activity and inhibition on prolactin secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetamides; Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Hypothalamus, Middle; Melatonin; Naphthalenes; Neurons; Ovariectomy; Prolactin; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Drug Synergism; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Melatonin; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Serotonin; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Nycthemeral variations of cholecystokinin action on intestinal motility in rats: effects of melatonin and S 20928, a melatonin receptor antagonist.
Topics: Animals; Cholecystokinin; Circadian Rhythm; Darkness; Duodenum; Fasting; Gastrointestinal Motility; Ileum; Jejunum; Light; Male; Melatonin; Naphthalenes; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Sincalide | 2000 |
Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipose Tissue; Animals; Biological Transport; Circadian Rhythm; Colforsin; Linoleic Acid; Liver Neoplasms, Experimental; Male; Melatonin; Naphthalenes; Neoplasm Transplantation; Pertussis Toxin; Rats; Rats, Inbred BUF; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Signal Transduction; Specific Pathogen-Free Organisms; Time Factors; Virulence Factors, Bordetella | 2001 |
Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Epididymis; Groin; Isoproterenol; Lipolysis; Male; Melatonin; Naphthalenes; Osmolar Concentration; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Virulence Factors, Bordetella | 2001 |
MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Intercellular Signaling Peptides and Proteins; Melatonin; Mucins; Muscle Proteins; Naphthalenes; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Peptides; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Melatonin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Transfection; Trefoil Factor-2; Trefoil Factor-3; Tumor Cells, Cultured | 2002 |
Melatonin inhibits nitrate tolerance in isolated coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Isoproterenol; Melatonin; Muscle, Smooth, Vascular; Naphthalenes; Nitrates; Nitroglycerin; Receptors, Melatonin; Swine; Tachyphylaxis; Time Factors; Tryptamines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2003 |
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.
Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Recovery of Function | 2004 |